Dr. Linas Kazlauskas, MD is a radiation oncology specialist in Glendale, CA and has been practicing for 27 years. He specializes in radiation oncology.


Locations

City of Hope Glendale Radiation Oncology

New Patient?
(818) 839-2411
1
  • Call
  • Fax
  • Hours
    • Mon: 8:00am - 5:00pm
    • Tue: 8:00am - 5:00pm
    • Wed: 8:00am - 5:00pm
    • Thu: 8:00am - 5:00pm
    • Fri: 8:00am - 5:00pm
    • Sat: closed
    • Sun: closed
  • Directions

Insurance Check

Search for your insurance provider

Dr. Kazlauskas accepts

Accepted insurance can change. Please double-check when making an appointment.

(818) 839-2411

Dr. Kazlauskas accepts the following insurance:

Aetna
Aetna HMO
Basic HMO
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Blue Cross Blue Shield of California
Blue Cross Blue Shield of California PPO
Priority Select HMO
Select Plus HMO
Blue Shield of California
Access Plus Savenet
Local Access Plus HMO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
Molina Healthcare
MultiPlan
PHCS Network PPO

Background Check

No malpractice claims found for California
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Kazlauskas' experience treating your condition or procedure

Dr. Kazlauskas' Top Procedures and Conditions

Treatment Frequency
Cancer
normal
normal

Treatment Frequency

Dr. Kazlauskas treats Cancer more than 63% of his peers

Dr. Kazlauskas treats this condition more than 63% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Colorectal Cancer
normal
normal

Treatment Frequency

Dr. Kazlauskas treats Colorectal Cancer more than 5% of his peers

Dr. Kazlauskas treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Distal Colorectal Cancer
  • Familial Colorectal Cancer
  • Hamartomatous Colorectal Cancer
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Rectal Cancer
  • Sporadic Colorectal Cancer
Prostate Cancer
normal
normal

Treatment Frequency

Dr. Kazlauskas treats Prostate Cancer more than 5% of his peers

Dr. Kazlauskas treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Primary Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15

Dr. Kazlauskas' conditions and procedures:

  • 3D Conformal Radiotherapy
  • Bladder Cancer
  • Brain Cancer
  • Brain Tumor
  • Breast Cancer
  • Breast Cancer Treatment
  • Cancer
  • Cancer Treatment
  • Cervical Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • External Beam Radiotherapy
  • Gynecologic Cancer
  • Image-Guided Radiation Therapy (IGRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Laryngeal Cancer
  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Pituitary Gland Cancer
  • Prostate Cancer
  • Radiation Oncology Procedures
  • Radiation Therapy
  • Rectal Cancer
  • Sarcoma
  • Skin Cancer
  • Vulvar Cancer

About Me

Linas Kazlauskas, MD, joined Valley Radiotherapy Associates in 2001 and is a board certified Radiation Oncologist. Dr. Kazlauskas practices at and is the medical director of Glendale Radiation Therapy Center in Glendale, CA. A Chicago-area native, he...

Specialties

  • Radiation Oncology

Education

Rush University
Internship Hospital
1992
Rush University Medical Center
Residency Hospital
1988
Rush Medical College Of Rush University
Medical School
1984
Loyola University Chicago
Undergraduate School
1992
1988
1984

Languages

  • Lithuanian
  • English

Dr. Kazlauskas' Reviews

Likelihood to recommend Dr. Kazlauskas

4.0

Based on 7 reviews

5 Stars
71.42857142857143%
(5)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
14.285714285714286%
(1)
1 Star
14.285714285714286%
(1)

Leave a review

How likely are you to recommend
Dr. Kazlauskas?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Kazlauskas' Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Linas Kazlauskas, MD
Reply
I was diagnosed with oral cancer on the base of my tongue into my throat. I was told by 3 different oncologists that radiation treatment, if not done well, in this area could have horrible, long lasting side effects. The staff at this City of Hope satellite office is kind, courteous, professional and genuinely personable. I immediately felt comfortable in the most trying time of my life. Dr. Linas Kazlauskas was the Dr. that I needed. He was patient, consoling, knowledgeable and so informative.
Was this helpful?
thumbs up icon option1
thumbs down icon option
×Post a ResponseAre you Dr. Linas Kazlauskas, MD?

Leave a review

How was your experience with Dr. Kazlauskas?

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Kazlauskas treats patients.

Learn more